Volume 16, Issue 3

Introduction- A Nighantu is a glossary of names used to identify Ayurvedic substances. [1] Kaiyadeva Nighantu, stands out for integrating medicine, diet and lifestyle in a unified framework. It is a classical Ayurvedic lexicon that systematically describes medicinal, dietary and lifestyle-related substances. It presents a concise and practical classification of dravyas, highlighting their nomenclature and therapeutic relevance. The text remains important for accurate drug identification and holistic Ayurvedic practice. Methodology- The review is based on classical Ayurvedic texts, Kaiyadeva Nighantu and relevant scholarly literature. Results- Kaiyadeva Nighantu classifies substances into eight Vargas: Aushadhi, Dhatu-Dhanya, Drava, Mamsa, Krita-Anna, Vihara, Mishraka and Nanarthaka, covering medicines, foods, liquids, lifestyle factors, and polysemous terms. Discussion- The text provides a clear and holistic classification useful for clinical practice, though some descriptions require modern scientific correlation. Conclusion- Kaiyadeva Nighantu remains a concise and relevant reference for Ayurvedic drug identification and integrated health practice.

Introduction: Bilvadi Churna is a classical Ayurvedic formulation described in Chakradatta under Balaroga Chikitsa for the management of Atisara (diarrhoea) in children. The formulation comprises Bilva (Aegle marmelos), Dhataki (Woodfordia fruticosa), Sugandha Bala (Valeriana wallichii), Gajapippali (Scindapsus officinalis) and Lodhra (Symplocos racemosa). The granule dosage form has the benefits of easy administration, better palatability, and longer shelf life. Objective: To study the pharmacological evidences of Bilvadi Churna (Granules) and its components. Materials and Methods: A comprehensive literature review was conducted using databases such as PubMed, Scopus, Google Scholar, DHARA, and AYUSH Research Portal. Classical Ayurvedic texts were also reviewed. Relevant studies from the last two decades were included. Observations: The components of drug, Bilvadi Churna have shown several pharmacological properties including anti-diarrhoeal, antimicrobial, anti-inflammatory, antioxidant, and digestive stimulant activities. Conclusion: Bilvadi Churna (Granules) shows promising therapeutic potential in diarrhoea. However, further well-designed clinical trials are necessary to establish its efficacy and safety in children.